B. Braun announced that it plans to invest $20 million to expand and modernize a medical device manufacturing facility in Pennsylvania. The project should create at least 200 new, full-time jobs over the next three years and retain 1,704 existing positions at the Lehigh Valley plant. The Commonwealth of Pennsylvania put forth its support for […]
Analysts label Embecta ‘undervalued’ and poised for growth
BTIG analysts maintain a “Buy” rating for Embecta (Nasdaq:EMBC) after meetings with company officials highlighted plans for growth. Marie Thibault, Sam Eiber and Alexandra Pang hosted Embecta CEO Devdatt Kurdikar and Head of Investor Relations Pravesh Khandelwal this week. Following the in-person and virtual meetings, the analysts maintain confidence in the former BD Diabetes unit’s […]
Vivani sets date for neuromod spin-off as focus turns to drug delivery implant
Vivani Medical (Nasdaq:VANI) announced today that it set a record date for the approved spin-off of its Cortigent subsidiary. In May, the Alameda, California-based company announced plans to spin off Cortigent, its division developing brain implants. The company wants to create two focused companies dedicated to driving current and future value in their respective therapeutic […]
Tandem reports positive outcomes for automated insulin delivery in type 2 regardless of C-peptide levels
Tandem Diabetes Care (Nasdaq:TNDM) today announced study findings highlighting the benefits of its automated insulin delivery system. Findings from the “Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level” study were published in the American Diabetes Association’s Diabetes Care. The study, a sub-analysis from the 2IQP trial, found that Control-IQ+ automated […]
Dexcom CEO takes temporary leave of absence
Dexcom (Nasdaq:DXCM) today filed an SEC form to announce that Chair and CEO Kevin Sayer is taking a temporary medical leave of absence. Sayer’s leave went into effect on Sept. 14, 2025. The Dexcom board appointed Jake Leach to serve as interim principal executive officer, in addition to his current duties as president and COO. Leach […]
Modular Medical can start insulin patch pump feasibility study
Modular Medical (Nasdaq:MODD) announced that it received Institutional Review Board (IRB) approval to study its next-generation insulin pump. San Diego-based Modular Medical can now conduct an in-house feasibility study for its next-generation Pivot insulin delivery system. The company plans for the study of the new pump to use sterile saline. Modular Medical unveiled Pivot, its […]
Roche wins CE mark for CGM, mySugr integration, presents positive clinical data
Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app. The Basel, Switzerland-based company — one of the largest diabetes tech companies in the world — announced the milestone, along with new real-world evidence for its continuous glucose monitoring (CGM) solution, at the European Association […]
Medtronic reports positive 3-year automated insulin delivery data
Medtronic (NYSE:MDT) today shared three-year real-world evidence highlighting improvements with its MiniMed 780G automated insulin delivery system. MiniMed 780G, the company’s latest-generation AID system, offers meal detection technology and provides automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs. Data demonstrated rapid, sustained […]
Insulet makes CFO change, appoints longtime J&J leader
Insulet (Nasdaq:PODD) announced today that it appointed Flavia Pease to succeed Ana Maria Chadwick as EVP and CFO. The transition goes into effect on Sept. 30, 2025, Chadwick intends to become a senior advisor to Insulet to ensure a smooth transition. “I want to personally thank Ana, who has provided steady and thoughtful leadership for […]
BD expands Alaris recall after identifying new potential issue
BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system. The expansion builds on a voluntary recall expanded earlier this year, informing customers of worst-case performance instances. Under certain cases, the pump, when used with a subset of compatible infusion sets, fails to perform as […]
